Why glucocorticoids ought to be kept on the World Antidoping Agency's list of banned products

British Journal of Sports Medicine

Volumn 42, Issue 12, 2008, Pages 946-947

  Montalvan, Bernard ^a   Duclos, Martine ^b  

^a French Tennis Federation   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETIC PERFORMANCE; DOPING IN SPORTS; GLUCOCORTICOIDS; HUMANS; RISK FACTORS;

EID: 58049193968     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsm.2008.053397     Document Type: Editorial

References (14)

1. Marquet P, Lac G, Chassain AP, et al. Dexamethasone in resting and exercising men. I. Effects on bioenergetics, minerals, and related hormones. J Appl Physiol 1999;87:175-82.
2. Petrides J, Gold PW, Mueller GP, et al. Marked differences in functioning of the hypothalamic-pituitary-adrenal axis between groups of men. J Appl Physiol 1997;82:1979-88.
3. Ruzzin J, Jensen J. Contraction activates glucose uptake and glycogen synthase normally in muscles from dexamethasone-treated rats. Am J Physiol Endocrinol Metab 2005;289:E241-50.
4. Duclos M, Gatti C, Bessiere B, et al. Tonic and phasic effects of corticosterone on food restriction-induced hyperactivity in rats. Psychoneuroendocrinology 2008; in press.
5. Duclos M, Konsmann JP, Bertin MA, et al. Paradoxical hyperactivity in food-restricted rats: a neuroendocrine hypothesis. Joint Meeting of British Society for Neuroendocrinology and Société de Neuroendocrinologie, 2005.
6. Short KR, Nygren J, Bigelow ML, et al. Effect of short-term prednisone use on blood flow, muscle protein metabolism, and function. J Clin Endocrinol Metab 2004;89:6198-207.
7. Iuchi T, Akaike M, Mitsui T, et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003;92:81-7.
8. Duclos M, Gouarne C, Martin C, et al. Effects of corticosterone on muscle mitochondria identifying different sensitivity to glucocorticoids in Lewis and Fischer rats. Am J Physiol 2004;286:E159-67.
9. Davis SN, Shavers C, Costa F, et al. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 1996;98:680-91.
10. McGregor VP, Banarer S, et al. Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia. Am J Physiol Endocrinol Metab 2002;282:E770-7.
11. Guinot M, Duclos M, Idres N, et al. Value of basal serum cortisol to detect corticosteroid-induced adrenal insufficiency in elite cyclists. Eur J Appl Physiol 2007;99:205-16.
12. Henzen C, Suter A, Lerch E, et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000;355:542-5.
13. Broide J, Soferman R, Kivity S, et al. Low-dose adrenocorticotropic test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995;80:1243-6.
14. Kannisto S, Korpi M, Arikoski P, et al. Biochemical marker of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy. Pediatr Res 2002;52:258-62.